Mark Ratner. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Bispecific/biosynthesisAntibodies, Bispecific/therapeutic useCancer Vaccines/immunologyCancer Vaccines/therapeutic useCell-Free SystemHumansImmunotherapyNeoplasms/immunologyNeoplasms/therapyProtein Biosynthesis
Substances: See more » Antibodies, BispecificCancer Vaccines
Year: 2014 PMID: 25489819 DOI: 10.1038/nbt1214-1175
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908